超越家族病史，将其作为高危人群胰腺癌监测的纳入标准。 - Suppr

Suppr

超能文献

Reaching beyond family history as inclusion criteria for pancreatic cancer surveillance in high-risk populations.

作者信息

Wang Louise, Domchek Susan M, Kochman Michael L, Katona Bryson W

出版信息

Genes Cancer. 2022 Aug 29;13:49-51. doi: 10.18632/genesandcancer.223. eCollection 2022.

DOI:10.18632/genesandcancer.223

PMID:36051752

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9423661/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e15f/9423661/0552555908fb/ganc-13-223-g001.jpg

相似文献

Reaching beyond family history as inclusion criteria for pancreatic cancer surveillance in high-risk populations.超越家族病史，将其作为高危人群胰腺癌监测的纳入标准。

Genes Cancer. 2022 Aug 29;13:49-51. doi: 10.18632/genesandcancer.223. eCollection 2022.

EUS-based Pancreatic Cancer Surveillance in Carriers Without a Family History of Pancreatic Cancer.基于 EUS 的胰腺癌监测在无胰腺癌家族史的携带者中。

Cancer Prev Res (Phila). 2021 Nov;14(11):1033-1040. doi: 10.1158/1940-6207.CAPR-21-0161. Epub 2021 Aug 2.

Pancreatic Cancer Surveillance: Who, When, and How.胰腺癌监测：对象、时机与方式。

Curr Treat Options Gastroenterol. 2019 Dec;17(4):681-691. doi: 10.1007/s11938-019-00247-0.

Pancreatic Cancer Surveillance and Novel Strategies for Screening.胰腺癌监测与新型筛查策略。

Gastrointest Endosc Clin N Am. 2022 Jan;32(1):13-25. doi: 10.1016/j.giec.2021.08.008.

Review of the cost-effectiveness of surveillance for hereditary pancreatic cancer.遗传性胰腺癌监测的成本效益综述。

Fam Cancer. 2024 Aug;23(3):351-360. doi: 10.1007/s10689-024-00392-1. Epub 2024 May 25.

Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium.家族性胰腺癌风险增加患者的管理：国际胰腺癌筛查 (CAPS) 联盟的最新建议。

Gut. 2020 Jan;69(1):7-17. doi: 10.1136/gutjnl-2019-319352. Epub 2019 Oct 31.

Role of Endoscopic Ultrasound in Detecting Pancreatic Cancer Missed on Cross-Sectional Imaging in Patients Presenting with Pancreatitis: A Retrospective Review.内镜超声在胰腺炎患者中检测到影像学漏诊的胰腺癌的作用：一项回顾性研究。

Dig Dis Sci. 2019 Dec;64(12):3623-3629. doi: 10.1007/s10620-019-05807-z. Epub 2019 Sep 16.

The role of endoscopic ultrasound in the detection of pancreatic lesions in high-risk individuals.内镜超声在高危个体胰腺病变检测中的作用。

Fam Cancer. 2024 Aug;23(3):279-293. doi: 10.1007/s10689-024-00380-5. Epub 2024 Apr 4.

Identification of individuals at high-risk for pancreatic cancer using a digital patient-input tool combining family cancer history screening and new-onset diabetes.使用结合家族癌症病史筛查和新发糖尿病的数字患者输入工具识别胰腺癌高危个体。

Prev Med Rep. 2023 Jan 16;31:102110. doi: 10.1016/j.pmedr.2023.102110. eCollection 2023 Feb.

Low Rates of Malignancy and Mortality in Asymptomatic Patients With Suspected Neoplastic Pancreatic Cysts Beyond 5 Years of Surveillance.无症状可疑胰腺肿瘤性囊肿患者经 5 年以上监测后，恶性肿瘤和死亡率较低。

Clin Gastroenterol Hepatol. 2016 Jun;14(6):865-871. doi: 10.1016/j.cgh.2015.11.013. Epub 2015 Dec 2.

引用本文的文献

BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients: A Review.BRCA1、BRCA2 及相关男性患者的癌症风险和管理：综述。

JAMA Oncol. 2024 Sep 1;10(9):1272-1281. doi: 10.1001/jamaoncol.2024.2185.

Review of the cost-effectiveness of surveillance for hereditary pancreatic cancer.遗传性胰腺癌监测的成本效益综述。

Fam Cancer. 2024 Aug;23(3):351-360. doi: 10.1007/s10689-024-00392-1. Epub 2024 May 25.

Artificial Intelligence in the Diagnosis and Treatment of Pancreatic Cystic Lesions and Adenocarcinoma.人工智能在胰腺囊性病变和腺癌诊断与治疗中的应用

Cancers (Basel). 2023 Apr 22;15(9):2410. doi: 10.3390/cancers15092410.

Gastric Cancer Risk and Pathogenesis in and Carriers.[基因名称]携带者的胃癌风险与发病机制

Cancers (Basel). 2022 Dec 1;14(23):5953. doi: 10.3390/cancers14235953.

本文引用的文献

The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival.多中心胰腺癌筛查研究：对分期和生存的影响。

J Clin Oncol. 2022 Oct 1;40(28):3257-3266. doi: 10.1200/JCO.22.00298. Epub 2022 Jun 15.

ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations.美国胃肠内镜学会关于对具有遗传易感性个体进行胰腺癌筛查的指南：总结与建议

Gastrointest Endosc. 2022 May;95(5):817-826. doi: 10.1016/j.gie.2021.12.001. Epub 2022 Feb 16.

Cancer Risks Associated With and Pathogenic Variants.与 BRCA1/2 基因和致病变异相关的癌症风险。

J Clin Oncol. 2022 May 10;40(14):1529-1541. doi: 10.1200/JCO.21.02112. Epub 2022 Jan 25.

Timeline of Development of Pancreatic Cancer and Implications for Successful Early Detection in High-Risk Individuals.胰腺癌的发展时间表及其对高风险个体成功早期检测的意义。

Gastroenterology. 2022 Mar;162(3):772-785.e4. doi: 10.1053/j.gastro.2021.10.014. Epub 2021 Oct 19.

EUS-based Pancreatic Cancer Surveillance in Carriers Without a Family History of Pancreatic Cancer.基于 EUS 的胰腺癌监测在无胰腺癌家族史的携带者中。

Cancer Prev Res (Phila). 2021 Nov;14(11):1033-1040. doi: 10.1158/1940-6207.CAPR-21-0161. Epub 2021 Aug 2.

Threshold Analysis of the Cost-effectiveness of Endoscopic Ultrasound in Patients at High Risk for Pancreatic Ductal Adenocarcinoma.内镜超声检查在高风险胰腺导管腺癌患者成本效益的阈值分析。

Pancreas. 2021 Jul 1;50(6):807-814. doi: 10.1097/MPA.0000000000001835.

Estimated Projection of US Cancer Incidence and Death to 2040.预估 2040 年美国癌症发病与死亡人数。

JAMA Netw Open. 2021 Apr 1;4(4):e214708. doi: 10.1001/jamanetworkopen.2021.4708.

Long-term yield of pancreatic cancer surveillance in high-risk individuals.高危人群的胰腺癌监测的长期获益。

Gut. 2022 Jun;71(6):1152-1160. doi: 10.1136/gutjnl-2020-323611. Epub 2021 Apr 5.

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.遗传/家族性高风险评估：乳腺癌、卵巢癌和胰腺癌，第 2.2021 版，NCCN 肿瘤学临床实践指南。

J Natl Compr Canc Netw. 2021 Jan 6;19(1):77-102. doi: 10.6004/jnccn.2021.0001.

AGA Clinical Practice Update on Colorectal and Pancreatic Cancer Risk and Screening in BRCA1 and BRCA2 Carriers: Commentary.美国胃肠病学会关于BRCA1和BRCA2基因携带者结直肠癌和胰腺癌风险及筛查的临床实践更新：评论

Gastroenterology. 2020 Aug;159(2):760-764. doi: 10.1053/j.gastro.2020.03.086. Epub 2020 Apr 23.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验